Contract Research Organisation (CRO):

Content Related to Contract Research Organisation (CRO)


• What CROs and CMOs Can Learn from Q3 Outsourcing Data and 2011 Trends
  

  Nice Insights quarterly Pharmaceutical and Biotechnology Outsourcing Survey is sent to 40,000+ pharmaceutical and biotechnology executives, and with results now published for the first three quarters in 2011, interesting trends begin to emerge. In the Q3 survey report, the largest segment of respondents (29%) represented Big Pharma companies for the third consecutive quarter. This was followed close....Read more
  

  
  Contributor:  Victor Coker and Mark Allen
  Tags: CMO | CRO | outsourcing
  11/03/2011  12:00:00 AM EDT

• Potential and Capabilities of the Clinical Research Sector Clinical research organisations, play an essential role within the drug development process. From large international firms, to smaller niche companies, clinical research organisations are relied upon by the pharmaceutical manufacturers to conduct clinical trials. The patents due to expire on a number of blockbuster drugs in the coming months mean that the pharmaceutical industry is l....Read more

  Contributor:  Pharma IQ Tags: CRO | CROs | clinical research organisation 10/07/2010  12:00:00 AM EDT

• 	Logistics for Clinical Trials in Emerging Markets Mark Walls, Director of Clinical Pharmacy at Human Genome Sciences, speaks to Andrea Charles from Pharma IQ, about the logistical challenges facing clinical trials and avoiding common mistakes for logistics in emerging countries. He also talks about the need for pharmaceutical and biotech companies to
  Contributor:   Pharma IQ Tags: Mark Walls | clinical trials supply. clinical trials logistics | clinical trials emerging markets 08/20/2010  12:00:00 AM EDT

• Career Spotlight: Clinical Research Coordinator Working as a clinical research coordinator or a clinical research associate can prove both a challenging and rewarding career. Those who excel in the profession often have strong scientific knowledge, excellent organisational skills and the ability to analyse and think logically. These researchers are involved in the creation and implementation of clinical trials to establish if products are suit....Read more

  Contributor:  Pharma IQ Tags: clinical research coordinator | clinical research coordinator jobs | clinical research coordinator certification 08/31/2010  12:00:00 AM EDT

• Pharmaceutical Outsourcing, Where Do You Draw the Line? The real issue in pharma is budget and structural change. There are no magic methods  to overcome what Richard Nelson called "the simple economics of basic scientific research—patents or no patents, capturing the value that ultimately derives from fundamental research is extraordinarily difficult for profit-oriented organisations. “The world is changing fast and pharma runs an outda....Read more

  Contributor:  Cristina Falcão Tags: Cristina Falcão | pharmaceutical outsourcing | outsourcing 05/20/2011  12:00:00 AM EDT

• Benchmarking Your Pharmaceutical Contract Manufacturing Strategies in 2013 As a thank you, all participants who complete the survey by 28th March are automatically entered in a prize draw for a free place at Pharma IQ’s 6th Annual Global Pharma Contract Manufacturing Summit. All respondents will get a copy of the results as well. Any questions don't hesitate to get in touch on enquire@iqpc.co.uk   Create your free online surveys with SurveyMonkey ,....Read more

  Contributor:  Pharma IQ Surveys Tags: pharmaceutical contract manufacturing in 2013 | 2013 CMOs | CMO 03/13/2013  12:00:00 AM EDT

• FDA Concerned About Lack of PI Oversight in Early Phase Clinical Trials In part one of this interview Dan Sfera from The Clinical Trials Guru, speaks to Andrea Charles from Pharma IQ, about the big trends making an impact in clinical research, the FDA's concern over the lack of PI oversight in clinical trials and getting involved in phase one studies. Pharma IQ: What really big trends you are seeing in clinical research? D Sfera: It'....Read more

  Contributor:  Andrea Charles Tags: PI oversight | principal investigator | early phase clinical trials 08/14/2012  12:00:00 AM EDT

• India Looks to a Future in Clinical Trials If the recent recession highlighted anything to firms in all sectors, it was how important it is for them to focus on their core competencies. On occasion, companies can be led away from their primary concern or speciality, which in turn can impact on their success and financial security. Such issues are prevalent in the competitive world of pharmaceuticals, where drug developers must work quickly t....Read more

  Contributor:  Pharma IQ Tags: clinical trials | clinical research | CRO 07/30/2010  12:00:00 AM EDT

• Why Are We Going to Move to Another CRO? Antonio Llamas, Regional Head of Operations in Spain and Portugal for Wyeth Research, joins Pharma IQ, to discuss global clinical outsourcing. To listen to the podcast go to Strategies for Selecting CROs and Keeping Partnerships on Track. Pharma IQ: Now, to start us off, could you just tell us, from your perspective, what changes or progression has been made within the market in recent years? ....Read more

  Contributor:  Richard de Silva Tags: Antonio Llamas | Wyeth Research | CRO 02/14/2011  12:00:00 AM EST

• Is Your Clinical Outsourcing Clear? In the pharmaceutical industry, the majority of companies now outsource the clinical trial process, with a massive 67 per cent of pharma and bio organisations outsourcing more than half of their trials. Companies recognise that clinical development is both unpredictable and time-consuming, and it is estimated that inefficiencies in the process lead to seven out of ten trials being delayed or cancell....Read more

  Contributor:  Pharma IQ Tags: clinical outsourcing | CRO | CROs 02/22/2011  12:00:00 AM EST

• 	Choosing a New CMO? The Cost of Change is Critical Richard Loughlin, Director, Contract Manufacturing Business Development North America, Commercial & External Partnerships (CEPiA) sanofi aventis, joins Andrea Charles from Pharma IQ, to discuss contract manufacturing trends and the a dvantages of using a CMO to enter a new market. Loughlin
  Contributor:   Andrea Charles Tags: Richard Loughlin | Sanofi-Aventis | CMO 05/03/2011  12:00:00 AM EDT

• Effectively Choosing a CRO that Best Suits Your Needs You only need to search on Google to find the endless list of global and local contract research service providers. The current Contract Research Organisation (CRO) landscape is vast, with offerings from functional to a full service CROs, such as Covance, Parexel and Quintiles. Using a CRO’s expertise can maximise the efficiency of your clinical trials, but only if you choose the right one ....Read more

  Contributor:  Andrea Charles Tags: CRO | contract research organisation | CROs 07/16/2010  12:00:00 AM EDT

• 	Best Practice Tips for Overcoming Obstacles in Biomarker Development How can we overcome the latest challenges in Biomarker Development? Birgitte Søgaard, Divisional Director for Clinical Pharmacology and Translational Medicine at H Lundbeck A/S, discusses with Helen Winsor from Pharma IQ, the key challenges in this area, in particular the need for
  Contributor:   Pharma IQ Tags: Birgitte Sogaard | phase 1 | phase one 07/29/2010  12:00:00 AM EDT

• Unlocking the Value of Strategic Partnerships with CRO’s and Pharmaceutical Companies in Asia Introduction Considering potential benefits and the impact of pitfalls of any Asian offshoring ambitions you need to analyse your situation and intentions first to establish the right base to unlock the value of your planned strategic partnerships or any other Asian ambitions which might be based on different business models than partnerships. The pharmaceutical industry started to offshore rel....Read more

  Contributor:  Frank Floether Tags: Frank Floether | Asian offshoring | strategic partnerships 03/02/2011  12:00:00 AM EST

• 	Managing Quality Relationships with CMOs is Critical for Success In this Pharma IQ podcast, Diane Petitti, Vice President, Quality at Amylin Pharmaceuticals, speaks to Andrea Charles from Pharma IQ, about the current challenges relating to domestic and overseas outsourced manufacturing and how to determine the best CMO for your company's needs. Petitti
  Contributor:   Pharma IQ Tags: Diane Petitti | contract manufacturing | quality 09/16/2010  12:00:00 AM EDT

• 	Working with an Overseas CMO to Gain FDA Inspection and Approved Status Pharma IQ speaks with Earl Sullivan, Chief Executive Officer, Landela Pharmaceutical, about working with an overseas CMO to gain FDA inspection and approved status.
  Contributor:   Pharma IQ Tags: Earl Sullivan | Landela Pharmaceutical | contract manufacturing 04/21/2010  12:00:00 AM EDT

• Balancing Ethics with Economy in Outsourced Clinical Trials Concerns are frequently raised in the pharmaceutical industry over the danger that when clinical trials are outsourced to contact research organisations (CROs), ethical protections might take a backseat to quicker and cheaper new product development. Outsourcing of trials to CROs and offshoring to developing economies, emphasises the need for independent monitoring and compulsory registration. This ....Read more

  Contributor:  Pharma IQ Tags: clinical trials outsourcing | clinical trials | CDISC 04/19/2011  12:00:00 AM EDT

• A Specialised Approach to Maximising Innovation for Small Biotechs and Start Ups While tremendous pricing pressure has led some companies to make deep price cuts, maintaining strong relationships and ensuring high business value from outsourcing is of great concern. In this Q&A interview, Ajit Narang, Senior Research Investigator, Drug Product Science & Technology at Bristol Myers Squibb, discusses establishing strong relationships with your outsourcing partners and key point....Read more

  Contributor:  Ajit Narang Tags: Ajit Narang | Bristol Myers Squibb | outsourcing 09/12/2011  12:00:00 AM EDT

• 	GSK's Peter Murray: Top Tips for Effective 3rd Party Management Peter Murray, Quality Director External Supply Strategy, GlaxoSmithKline, provides an overview of GSK's contract manufacturing strategy. In this interview with Andrea Charles from Pharma IQ, Murray discusses the drivers for external supply, CMO selection and supply chain strategy.
  Tags: Peter Murray | external supply strategy | contract manufacturing

• 	Merck Serono's Mathieu Collignon: Working with a CMO Mathieu Collignon, Associate Director CMO Marketed Products, Merck Serono, speaks to Andrea Charles from Pharma IQ, about the main challenges when working with a CMO, the importance of good communication and relationship management and being prepared for a virtual based pharmaceutical model.
  Tags: Mathieu Collignon | Merck Serono | contract manufacturing

A glossary of keywords, acronyms and general terminology used in day-to-day professional work, Pharma. If you would like to add to, edit or comment on this page, please drop us a line at info@pharma-iq.com